Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Taming glioblastoma: targeting angiogenesis.

× No keyword cloud information.

17 in total

1. Evaluation of diffusion parameters as early biomarkers of disease progression in glioblastoma multiforme.

Authors: Inas S Khayal; Mei-Yin C Polley; Llewellyn Jalbert; Adam Elkhaled; Susan M Chang; Soonmee Cha; Nicholas A Butowski; Sarah J Nelson
Journal: Neuro Oncol Date: 2010-05-25 Impact factor: 12.300

2. Assessment of perfusion MRI-derived parameters in evaluating and predicting response to antiangiogenic therapy in patients with newly diagnosed glioblastoma.

Authors: Emma Essock-Burns; Janine M Lupo; Soonmee Cha; Mei-Yin Polley; Nicholas A Butowski; Susan M Chang; Sarah J Nelson
Journal: Neuro Oncol Date: 2010-10-29 Impact factor: 12.300

3. Optic neuropathy in patients with glioblastoma receiving bevacizumab.

Authors: J H Sherman; D G Aregawi; A Lai; H M Fathallah-Shaykh; P J Bierman; K Linsky; J M Larner; S A Newman; D Schiff
Journal: Neurology Date: 2009-12-01 Impact factor: 9.910

4. Improved perfusion MR imaging assessment of intracerebral tumor blood volume and antiangiogenic therapy efficacy in a rat model with ferumoxytol.

Authors: Seymur Gahramanov; Leslie L Muldoon; Xin Li; Edward A Neuwelt
Journal: Radiology Date: 2011-09-21 Impact factor: 11.105

5. Diagnostic accuracy of proton magnetic resonance spectroscopy and perfusion-weighted imaging in brain gliomas follow-up: a single institutional experience.

Authors: Monica Anselmi; Alessia Catalucci; Valentina Felli; Valentina Vellucci; Alessandra Di Sibio; Giovanni Luca Gravina; Mario Di Staso; Ernesto Di Cesare; Carlo Masciocchi
Journal: Neuroradiol J Date: 2017-01-01

6. Salvage gamma knife stereotactic radiosurgery followed by bevacizumab for recurrent glioblastoma multiforme: a case-control study.

Authors: Kyung-Jae Park; Hideyuki Kano; Aditya Iyer; Xiaomin Liu; Ajay Niranjan; John C Flickinger; Frank S Lieberman; L Dade Lunsford; Douglas Kondziolka
Journal: J Neurooncol Date: 2011-11-05 Impact factor: 4.130

7. Dynamic magnetic resonance imaging assessment of vascular targeting agent effects in rat intracerebral tumor models.

Authors: Leslie L Muldoon; Seymur Gahramanov; Xin Li; Deborah J Marshall; Dale F Kraemer; Edward A Neuwelt
Journal: Neuro Oncol Date: 2010-12-01 Impact factor: 12.300

Review 8. Towards novel radiosensitizing agents: the role of cytosolic PLA2α in combined modality cancer therapy.

Authors: Jeffrey M Craft; Dennis Hallahan
Journal: Future Med Chem Date: 2011-05 Impact factor: 3.808

9. Efficacy, safety and patterns of response and recurrence in patients with recurrent high-grade gliomas treated with bevacizumab plus irinotecan.

Authors: R M Zuniga; R Torcuator; R Jain; J Anderson; T Doyle; S Ellika; L Schultz; T Mikkelsen
Journal: J Neurooncol Date: 2008-10-25 Impact factor: 4.130

10. Dynamic MRI using iron oxide nanoparticles to assess early vascular effects of antiangiogenic versus corticosteroid treatment in a glioma model.

Authors: Csanad G Varallyay; Leslie L Muldoon; Seymur Gahramanov; Yingjen J Wu; James A Goodman; Xin Li; Martin M Pike; Edward A Neuwelt
Journal: J Cereb Blood Flow Metab Date: 2009-01-14 Impact factor: 6.200